Private equity deals will have an important role in spine practices, but physicians should be mindful about the relationship that comes with investments, said David Essig, MD, of New Hyde Park, N.Y.-based Northwell Health.
The Latest
The FDA approved several spine-related devices last month.
From a revived lawsuit against a prominent commercial payer to a patent infringement case and a tainted spine product that may have gotten a patient sick, here are three spine cases that made headlines in the past month:
While CMS' decision last year to gradually phase out the inpatient-only list has been widely welcomed by the spine community, other regulatory changes related to reduced reimbursement and increased prior authorization requirements have not.
Samaritan Medical Center in Watertown, N.Y., has become the first hospital in the region to offer the Mako SmartRobotics system for joint replacements, InformNY.com reported June 18.
The Bone & Joint Center in Albany, N.Y., saw patient volumes decrease by about half during the COVID-19 pandemic and still is seeing some reluctance from patients to resume care for orthopedic conditions, the Albany Business Review reported June 18.
A 20-year-old baseball player from Fairfax, Va.-based George Mason University died after complications from Tommy John surgery, The New York Times reported June 19.
The Novartis gene therapy drug Zolgensma has led to significant improvements in motor function for presymptomatic children with spinal muscular atrophy, European Pharmaceutical Review reported June 21.
Palm Beach Gardens, Fla.-based American Orthopedic Partners is expanding with investment from Stone Point Capital, a private equity company, and two legendary orthopedic surgeons joining as board members.
A 91,000-square-foot orthopedic surgery center at the University of Tennessee Medical Center in Knoxville has reached its structural completion.